For individuals with chronic lung conditions, the winter season and the current cold snap poses significant challenges. We ...

(RTTNews) - 2024 has been a banner year for Verona Pharma (VRNA), with its share price surging more than threefold in just 7.5 months. The ...

We assessed socioeconomic covariates (mean copayments, total copayments, and unique brand-to-generic prescription ... glycopyrrolate-formoterol. Dry powder inhalers may not be suitable for all ...

Bovhyaluronidase azoximer, marketed under the brand name Longidaza ... A Phase 2 trial of inhaled Longidaza in patients with idiopathic pulmonary fibrosis is planned for 2025.

3/4 inhibitor – now given the somewhat tongue-twisting brand name of Ohtuvayre – is the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD ...

A new year, new breakthroughs! Join us for our annual tradition of compiling and revealing the most interesting things ...

Researchers will have more freedom to study its potential health benefits. Our country may be divided about many things, but when it comes to our health, there is plenty for all of us to celebrate.

In response to that investigation, three of the four manufacturers – Boehringer Ingelheim, AstraZeneca, and GSK- committed to cap patient out-of-pocket costs for their brand-name inhalers at $35.

In response to that investigation, three of the four manufacturers – Boehringer Ingelheim, AstraZeneca, and GlaxoSmithKline (GSK) – committed to cap patient out-of-pocket costs for their brand-name ..

Asthma inhalers are hand-held devices that allow you to inhale a dose of medication to treat asthma symptoms. There are many types of asthma inhalers. They differ in whether they're used for quick ...